SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-05-10 11:53
Tx date 2023-05-08 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$11,250
+75,000 vol
$0.15 each 		205,000
Filed 2023-02-02 20:45
Tx date 2023-02-01 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$1,837
+17,500 vol
$0.105 each 		419,077
Filed 2023-01-30 15:33
Tx date 2023-01-26 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$6,000
+50,000 vol
$0.12 each 		130,000
Filed 2023-01-18 11:22
Tx date 2023-01-17 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$26,749
+297,222 vol
$0.09 each 		401,577
Filed 2023-01-04 17:27
Tx date 2022-12-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$10,000
+100,000 vol
$0.10 each 		104,355
Filed 2023-01-04 17:26
Tx date 2022-12-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$10,000
+50,000 vol
$0.20 each 		50,000
Filed 2023-01-04 17:23
Tx date 2011-05-27 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2023-01-04 17:19
Tx date 2022-12-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$10,000
+100,000 vol
$0.10 each
Filed 2023-01-03 20:56
Tx date 2022-12-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$10,000
+100,000 vol
$0.10 each
Filed 2023-01-03 20:56
Tx date 2022-12-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$10,000
+100,000 vol
$0.10 each 		307,843
Filed 2021-06-16 13:46
Tx date 2021-06-15 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+75,000 vol
$0.40 each 		165,000
Filed 2021-06-03 17:03
Tx date 2021-06-02 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$10,749
+27,922 vol
$0.385 each 		207,843
Filed 2021-06-02 17:23
Tx date 2021-05-27 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
+4,355 vol 		4,355
Filed 2021-06-02 17:22
Tx date 2011-05-27 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-04 13:32
Tx date 2021-04-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$10,749
+27,922 vol
$0.385 each 		179,921
Filed 2020-08-19 15:27
Tx date 2020-08-14 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$13,750
+76,389 vol
$0.18 each 		151,999
Filed 2019-11-03 01:49
Tx date 2019-10-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$9,749
+34,821 vol
$0.28 each 		75,610
Filed 2019-09-13 10:47
Tx date 2019-09-10 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Convertible Preferred Shares Class A Preference Shares
11 - Acquisition or disposition carried out privately 		$15,000
+37,500 vol
$0.40 each 		37,500
Filed 2019-09-13 10:45
Tx date 2011-05-27 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Holder: Peter W. Lewis Inc. (Indirect Ownership)
Convertible Preferred Shares Class A Preference Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-01-18
Tx date 2019-01-15 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$16,999
+35,789 vol
$0.475 each 		40,789
Filed 2019-01-16
Tx date 2016-08-10 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-45,000 vol 		5,000
Filed 2019-01-16
Tx date 2018-07-30 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+50,000 vol 		90,000
Filed 2019-01-16
Tx date 2016-08-10 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-90,000 vol 		10,000
Filed 2019-01-16
Tx date 2016-12-07 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+30,000 vol 		40,000
Filed 2018-08-02
Tx date 2018-08-02 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$21,500
+50,000 vol
$0.43 each 		80,000
Filed 2016-12-29
Tx date 2011-05-27 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-12-29
Tx date 2016-12-29 		$RP
RepliCel Life Sciences Inc. 		Lewis, Peter Winston
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$18,000
+30,000 vol
$0.60 each 		30,000